Nancy Simonian

Nancy Simonian

Chief Executive Officer presso SYROS PHARMACEUTICALS, INC.

Patrimonio netto: 704 370 $ in data 31/03/2024

63 anni
Health Technology
Consumer Services
Commercial Services

Provenienza dei contatti di primo grado di Nancy Simonian

EntitàTipo di entitàSettore Industriale
Princeton University
256
College/University Other Consumer Services 256
242
Non-Profit Organization Miscellaneous Commercial Services 242
105
Subsidiary Pharmaceuticals: Major 105
Public Company Pharmaceuticals: Major 52
Subsidiary Pharmaceuticals: Major 51
Public Company Pharmaceuticals: Major 42
Public Company Biotechnology 39
36
Foundation/Endowment Miscellaneous Commercial Services 36
Public Company Pharmaceuticals: Major 17
Subsidiary Pharmaceuticals: Major 14
Perelman School of Medicine
5
College/University Other Consumer Services 5

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Nancy Simonian tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
Pharmaceuticals: Major

Mark B. Skaletsky

Katrine Bosley

Director/Board Member

Corporate Officer/Principal

AMGEN INC. Pharmaceuticals: Major

Fabrizio Bonanni

Helen Torley

William Sibold

Chief Operating Officer

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Mark B. Skaletsky

John Maraganore

President

Corporate Officer/Principal

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Tim Tyson

Helen Torley

Jeremy Levin

James Sapirstein

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Sales & Marketing

Biotechnology

Srini Akkaraju Akkaraju

Mark Levin

Jean-Jacques Bienaimé

Ted Love

David Schenkein

John Orwin

Corporate Officer/Principal

Corporate Officer/Principal

Sales & Marketing

General Counsel

Corporate Officer/Principal

Corporate Officer/Principal

GILEAD SCIENCES, INC. Biotechnology

John Milligan

James Meyers

Ted Love

James Sapirstein

Douglas Maffei

Chief Executive Officer

Corporate Officer/Principal

Director/Board Member

Sales & Marketing

Investor Relations Contact

IMMUNOGEN, INC. Biotechnology

Daniel Junius

Mark B. Skaletsky

Daniel Char

Chief Executive Officer

Director/Board Member

General Counsel

Pharmaceuticals: Major

Frederic Roch Doliveux

John Orwin

President

Corporate Officer/Principal

Washington University in St. Louis College/University

Mark Levin

Andrew Oh

Graduate Degree

Undergraduate Degree

Pharmaceuticals: Major

Helen Torley

Ted Love

Chief Operating Officer

Chief Tech/Sci/R&D Officer

ALEXION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Felix Baker

Deborah Dunsire

Jeremy Springhorn

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Medical Specialties

Marsha Fanucci

Steven J. Burakoff

Jean-Jacques Bienaimé

Peter Wirth

Gerald Quirk

William Sibold

Corporate Officer/Principal

Director/Board Member

Director/Board Member

General Counsel

Corporate Officer/Principal

President

Investment Managers

John Maraganore

David Schenkein

Private Equity Investor

Private Equity Investor

AGIOS PHARMACEUTICALS, INC. Pharmaceuticals: Major

John Maraganore

David Schenkein

Chairman

Chief Executive Officer

The Trustees of Columbia University in The City of New York College/University

Leon Cooperman

Norman Eig

Masters Business Admin

Corporate Officer/Principal

College/University

Jonathan Leff

Gerald Quirk

Undergraduate Degree

Graduate Degree

Stanford University College/University

Felix Baker

Srini Akkaraju Akkaraju

Barbara Kosacz

Yung S. Lie

Doctorate Degree

Doctorate Degree

Undergraduate Degree

Doctorate Degree

University of Pennsylvania College/University

John Fry

Christophe M. Bianchi

Carolyn J. Fritz

Chief Operating Officer

Masters Business Admin

Masters Business Admin

UCB Pharmaceuticals: Major

Frederic Roch Doliveux

Jean-Christophe Tellier

Chief Executive Officer

Chief Executive Officer

Financial Conglomerates

Margaret A. Gilliam

Leon Cooperman

Karen D. Seitz

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

University of Oxford College/University

Jeremy Levin

Stephen Hill

Alphonse Galdes

Undergraduate Degree

Doctorate Degree

Doctorate Degree

George Washington University College/University

Clay Siegall

Carolyn J. Fritz

Doctorate Degree

Graduate Degree

MACROGENICS, INC. Pharmaceuticals: Major

John Maraganore

Jean-Christophe Tellier

Chairman

Corporate Officer/Principal

ALNYLAM PHARMACEUTICALS, INC. Pharmaceuticals: Major

David Pyott

Marsha Fanucci

John Maraganore

Director/Board Member

Director/Board Member

Chief Executive Officer

INFINITY PHARMACEUTICALS, INC. Pharmaceuticals: Major

Steven Holtzman

Gerald Quirk

Founder

Investor Relations Contact

Boston College College/University

Daniel Junius

James Meyers

Peter van Camp

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

The University of Chicago College/University

Jeffrey Leiden

John Maraganore

Karen D. Seitz

Doctorate Degree

Doctorate Degree

Masters Business Admin

Yale University College/University

Christopher G. Standlee

Richard Young

William Sibold

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Tufts University College/University

Vaughn M. Kailian

Daniel Char

Undergraduate Degree

Undergraduate Degree

New York University College/University

Steven J. Burakoff

John Fry

John Orwin

Corporate Officer/Principal

Masters Business Admin

Masters Business Admin

University of California, Irvine College/University

Tim Tyson

Brian Atwood

Corporate Officer/Principal

Undergraduate Degree

University of Bonn College/University

Simone Bagel-Trah

Otmar D. Wiestler

Undergraduate Degree

Corporate Officer/Principal

Pharmaceuticals: Major

Tim Tyson

Deborah Dunsire

Jean-Jacques Bienaimé

James E. Hoyes

Jean-Christophe Tellier

Mark Timney

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Carl Feldbaum

Jeremy Levin

Ted Love

Director/Board Member

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Jeremy Levin

Ronald Cohen

Director/Board Member

Chairman

Wallon Institute for Life Lead Sciences

Frederic Roch Doliveux

Jean-Christophe Tellier

Director/Board Member

Director/Board Member

BLUEPRINT MEDICINES CORPORATION Biotechnology

Mark Levin

David Schenkein

Kyle Kuvalanka

Chairman

Director/Board Member

Director of Finance/CFO

Drugstore Chains

Frederic Roch Doliveux

Jean-Christophe Tellier

Chairman

Director/Board Member

Miscellaneous Commercial Services

Mark Levin

Steven Holtzman

Rachel King

Director/Board Member

Director/Board Member

Director/Board Member

Harvard Business School College/University

James Tobin

Brian Atwood

Rachel King

Simon Waddington

William Sibold

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Kellogg School of Management College/University

Daniel Junius

Colleen Goggins

Andrew Oh

Graduate Degree

Graduate Degree

Masters Business Admin

The Leonard N Stern School of Business College/University

John Fry

John Orwin

Jonathan Wolfson

Masters Business Admin

Masters Business Admin

Masters Business Admin

VTV THERAPEUTICS INC. Pharmaceuticals: Major

Srini Akkaraju Akkaraju

John Fry

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Srini Akkaraju Akkaraju

Richard Young

Director/Board Member

Founder

CARGO THERAPEUTICS, INC. Biotechnology

Srini Akkaraju Akkaraju

John Orwin

Director/Board Member

Chairman

Statistiche

Distribuzione geografica

Stati Uniti 46
Belgio 4
Regno Unito 2
Germania 2

Settori

Health Technology 27
Consumer Services 18
Commercial Services 4
Finance 3
Retail Trade 2

Posizioni

Director/Board Member 710
Corporate Officer/Principal 240
Independent Dir/Board Member 219
Chairman 157
Chief Executive Officer 138